Effects of RS17053 on α 1 ‐adrenoceptors in rat vas deferens and aorta
Fundamental & Clinical Pharmacology · 2023
DOI: 10.1111/fcp.12930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2023. Verfasst von Hadeel A Alsufyani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Prazosin, Vas Deferens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Abdullah University, Jeddah.
Abstract (Originalsprache)
Background
RS17053 is classed as an α 1A ‐adrenoceptor selective antagonist.
Objectives
We have examined its profile of action at all subtypes of α 1 ‐adrenoceptor.
Methods
Noradrenaline (NA) evoked contractions of rat vas deferens involve α 1D ‐adrenoceptors in phasic contractions and α 1A ‐adrenoceptors in tonic contractions. Contractions of rat aorta to NA involve α 1D ‐ and α 1B ‐adrenoceptors.
Results
RS17053 (10 −5 M) shifted NA potency and virtually abolished tonic contractions to NA, with little or limited effect on phasic contractions. The α 1D ‐adrenoceptor antagonist BMY7378 (3 × 10 −7 M) significantly inhibited the remaining phasic component of the contractions, and the α 1A ‐adrenoceptor antagonist RS100329 (10 −7 M) inhibited further the residual tonic contraction. Hence, RS17053 shows high selectivity for α 1A ‐adrenoceptors over α 1D ‐adrenoceptors in rat vas deferens. However, RS17053 (10 −5 M) produced a large shift in the potency of NA in rat aorta, with a pK B of 6.82. Large shifts of NA potency in rat aorta involve α 1B ‐adrenoceptor blockade.
Conclusion
Results in rat vas deferens demonstrate low potency of RS17053 at α 1D ‐adrenoceptors, but results from rat aorta can only be explained as demonstrating α 1B ‐adrenoceptor antagonism by RS17053. RS17053 may be a useful pharmacological tool when reclassified as a mainly α 1A ‐ and to a lesser extent α 1B ‐adrenoceptor antagonist with little effect at α 1D ‐adrenoceptors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland.
ORCID-Profile: Hadeel A Alsufyani, James R Docherty
Förderung
- Deanship of Scientific Research, King Abdullah University, Jeddah
Zitieren
APA
Alsufyani, H. A., & Docherty, J. R. (2023). Effects of RS17053 on α 1 ‐adrenoceptors in rat vas deferens and aorta. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.12930
Vancouver
Alsufyani HA, Docherty JR. Effects of RS17053 on α 1 ‐adrenoceptors in rat vas deferens and aorta. Fundamental & Clinical Pharmacology. 2023. doi:10.1111/fcp.12930
BibTeX
@article{Alsufyani2023,
author = {Alsufyani, Hadeel A and Docherty, James R},
title = {Effects of RS17053 on α 1 ‐adrenoceptors in rat vas deferens and aorta},
journal = {Fundamental & Clinical Pharmacology},
year = {2023},
doi = {10.1111/fcp.12930}
}
EUVIMED